SCHEMBL24463568

SCHEMBL24463568

Nc1cc(I)c(F)cc1NC1CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
ROCK2 O75116 1/20 0.40
ALOX15 P16050 2/20 0.35
BACE1 P56817 2/20 0.34
BACE2 Q9Y5Z0 2/20 0.34
CHEK1 O14757 1/20 0.34
NTRK1 P04629 1/20 0.34
MET P08581 1/20 0.34
PIM1 P11309 1/20 0.34
LTK P29376 1/20 0.34
GRK5 P34947 1/20 0.34
MAP2K2 P36507 1/20 0.34
CDK8 P49336 1/20 0.34
NEK2 P51955 1/20 0.34
LIMK1 P53667 1/20 0.34
TYRO3 Q06418 1/20 0.34
MAP4K2 Q12851 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24463483 0.93 ROCK2 (0.45) GAAKDM4EMAPTROCK2ALOX15
SCHEMBL30657517 0.86 GAA (0.46) GAAKDM4EMAPTROCK2ALOX15
SCHEMBL20349186 0.86 GAA (0.46) GAAKDM4EMAPTROCK2ALOX15
SCHEMBL24463566 0.82 ROCK2 (0.33) ROCK2
SCHEMBL24463551 0.80 KDM4E (0.41) GAAKDM4EMAPTALOX15NUDT1
SCHEMBL29525834 0.78 ROCK2 (0.46) GAAKDM4EMAPTROCK2ALOX15
SCHEMBL10175794 0.78 ROCK2 (0.46) GAAKDM4EMAPTROCK2ALOX15
SCHEMBL18583976 0.76 MAPT (0.50) GAAKDM4EMAPTALOX15CHEK1
SCHEMBL24463540 0.72 ALOX15 (0.36) GAAKDM4EMAPTROCK2ALOX15
SCHEMBL11964427 0.72 GAA (0.51) GAAKDM4EMAPTALOX15BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345681-B1 Inhibitors of fibroblast growth factor receptor kinases KINNATE BIOPHARMA INC. (US) 2022-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345681-B1 Inhibitors of fibroblast growth factor receptor kinases FGFR1, FGFR2, FGFR3 GAA 427/4885KDM4E 2742/4885MAPT 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.